The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- Keywords
- COVID-19, SARS-CoV-2, inhibitors, methyltransferase, nsp14 nsp10, structure-based design,
- MeSH
- COVID-19 * MeSH
- Exoribonucleases MeSH
- Humans MeSH
- Ligands MeSH
- Methyltransferases * genetics MeSH
- SARS-CoV-2 MeSH
- Viral Nonstructural Proteins MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Exoribonucleases MeSH
- Ligands MeSH
- Methyltransferases * MeSH
- Viral Nonstructural Proteins MeSH
In this study, we have focused on the structure-based design of the inhibitors of one of the two SARS-CoV-2 methyltransferases (MTases), nsp14. This MTase catalyzes the transfer of the methyl group from S-adenosyl-l-methionine (SAM) to cap the guanosine triphosphate moiety of the newly synthesized viral RNA, yielding the methylated capped RNA and S-adenosyl-l-homocysteine (SAH). As the crystal structure of SARS-CoV-2 nsp14 is unknown, we have taken advantage of its high homology to SARS-CoV nsp14 and prepared its homology model, which has allowed us to identify novel SAH derivatives modified at the adenine nucleobase as inhibitors of this important viral target. We have synthesized and tested the designed compounds in vitro and shown that these derivatives exert unprecedented inhibitory activity against this crucial enzyme. The docking studies nicely explain the contribution of an aromatic part attached by a linker to the position 7 of the 7-deaza analogues of SAH.
References provided by Crossref.org
Structural basis for broad-spectrum binding of AT-9010 to flaviviral methyltransferases
Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors
Crystal Structure of the ORP8 Lipid Transport ORD Domain: Model of Lipid Transport
Structure of monkeypox virus poxin: implications for drug design
Structural basis for SARS-CoV-2 nucleocapsid (N) protein recognition by 14-3-3 proteins
A Helquat-like Compound as a Potent Inhibitor of Flaviviral and Coronaviral Polymerases
Coronaviral RNA-methyltransferases: function, structure and inhibition
Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit
Structural Analysis of the OC43 Coronavirus 2'-O-RNA Methyltransferase